Beruflich Dokumente
Kultur Dokumente
Strategies
Mark Kantrow MD
OR, Everything a
nurse (and doctor!)
should know
about pain management
Objectives
Know basic steps of analgesic
management
Know basic conversions between
common opioids
Know adverse effects of analgesics, their
management
understand pain management at the end
of life
Pain
Neuropathic
Visceral
Somatic
direct
tissue
damage
direct
nerve
damage
Acute Pain
Short duration usually from trauma,
surgery or other injury
Variations in intensity
Pain behaviorsmoaning, rubbing
Anxiety
Sympathetic hyperactivitysweating,
tachycardia, hypertension
Chronic Pain
Variable onset with variable duration
Variable intensity
Behavior may not give away pain
Patient may be depressed or irritable or
stiff--unpleasant
Often the physical findings one sees in
acute pain are absent
Pain equation
Tissue damage
+
emotional + spiritual + social =
THE PAIN EXPERIENCE
WHO 3-step
3 severe
Ladder
Morphine
2 moderate
1
mild
ASA
Acetaminophen
NSAIDs
Adjuvants
Hydromorphone
Methadone
A/Codeine
Levorphanol
A/Hydrocodone
Fentanyl
A/Oxycodone
Oxycodone
A/Dihydrocodeine
Adjuvants
Tramadol
Adjuvants
Adjuvant Analgesics
Medications that supplement primary
analgesics
--Often have another primary use:
anticonvulsants, steroids,
antidepressants
May themselves be the primary
analgesics
May use at any step of the WHO ladder
Dyspnea
Opioid pharmacology .
..
Cmax after
po
1h
SC, IM 30 min
IV
6 min
Plasma Concentration
IV
SC / IM
Cmax
po / pr
Half-life (t1/2)
Time
Bolus Effect
Swings in plasma concentration
Drowsiness - 1 hour after ingestion
Pain before next dose due
Should move to extended release
preparation or continuous SC, IV
infusion with PCA
Extended Release
Improves compliance and pain reliefreduces bolus effect
provides background pain relief
Orally can dose q8, 12 or 24 (product
specific)
dont crush or chew tablets
May flush time-release granules down
feeding tubes (Kadian, Avinza)
Adjust q 2-4 days as steady state is
reached
Transdermal patch
Fentanyl
Peak effect after application in 12-24
hours
Patch lasts 48-72 hours
NOT for the opioid nave
Ensure adherence to skin
Must have subcutaneous fat to allow
absorptionnot for the cachectic
patient
Fever makes absorption unpredictable
Breakthrough dosing
Use immediate release opioids
Approximately 10% of the 24-h dose
May offer again after Cmax is reached
for previous dose
PO/PR q 1 hr
SC, IM q 30 minutes
IV q 15 minutes
Alternative Routes of
Administration
Enteral Feeding Tubes/ Oral
Transmucosal
Rectal
Transdermal
Parenteral (IV, SubQ, IM)
Intraspinal
Equianalgesic Chart
Drug
Dose(mg)
Parenteral
Dose (mg)
Oral
Duration
Hours
Morphine (IR)
10
30
3-4
Hydromorphone
1.5
7.5
3-4
Oxycodone
____
20
3-4
Equianalgesic Survival
Skills
IV morphine is THREE times as strong as
oral morphine
Equianalgesic Survival
Skills
IV Dilaudid is 5 times as strong as oral
1 mg Dilaudid IV equals 5 mg Dilaudid
p.o.
Little known fact:
1 mg Dilaudid IV = 7.5 mg Morphine
IV
Equianalgesic Survival
Skills
Morphine 5mg IVP = Percocet 10
(oxycodone)
Morphine 3mg IVP = Lortab 10
(hydrocodone)
Equinanalgesic
Survival Skills
Case 1
Your patient has been receiving
Morphine 5mg IVP q 4 hours prn and
now has lost her IV. The physician you
call orders a dose of oral Morphine
liquid 5mg q 4 hours.
DO THE MATH!
What do you say when you hear this?
Case #2
Mrs. Bourgeois is a 37y/o housewife who
has suffered from chronic back pain for
10 years following an MVA. She had a
laminectomy 2 years ago with only
minimal improvement in pain.
She takes MS Contin 60 BID as
prescribed by her pain management
physician as an outpatient and has
tolerable chronic pain.
She is admitted to your unit with a
retropharyngeal abscess and cannot
swallow.
Case #2 contd
The admitting physician writes for
Morphine 5 mg IV q 4 PRN pain.
DO THE MATH!
How do you expect this will manage her
pain?
How do you think this patient will be
regarded by the nursing and physician
staff?
Be careful of story we tell ourselves
PSEUDO-ADDICTION
*DRUG SEEKING
BEHAVIOR
Case 3
Mr. Sampson is a 45 y/o WM with bone
pain related to newly discovered
metastatic prostate CA. He is admitted
for poorly controlled pain. He is
tachycardic, diaphoretic and grimacing,
describing his pain as 10/10
Opioid allergy
Anaphylactic reactions are very rare with
opioids
Bronchospasm
Urticaria
Nausea / vomiting, constipation,
drowsiness, confusion
adverse effects, not allergic
reactions
PRURITIS
Mast cell destabilization with all opioids
causing itching
Treat with routine long-acting, nonsedating
antihistamines
Fexofenadine (Allegra), 60 mg po bid, or
Loratadine (Claritin)
Sedating antihistamines or doxepin if
sleep desired
Constipation . . .
Common to all opioids
One does not develop tolerance to this!
Opioid effects on CNS, spinal cord,
myenteric plexus of gut
Easier to prevent than treat
. . . Constipation
Diet usually insufficient to relieve
Bulk forming agents not recommended
(no metamucil!)
Stool Softener: senna, bisacodyl,
glycerine, casanthranol, etc
Stimulant laxative: Docusate sodium
senna + docusate sodium is best
combo
Constipation . . .
Prokinetic agent
metoclopramide
Osmotic laxative
MOM, lactulose, sorbitol
Other measures
Nausea / vomiting . . .
Onset with start of opioids- opioid naive
usually improves within days
Prevent or treat with dopamine-blocking
antiemetics or prokinetics
prochlorperazine, (Compazine) 10 mg q
6h
haloperidol, 1 mg q 6 h
metoclopramide,(Reglan) 10 mg q 6 h
Sedation . . .
*Onset with start of opioids
*distinguish from exhaustion
due to pain
* usually improves within
days
. . . Sedation
If persistent and undesired, rotate to
another opioid or change route of
administration
Psychostimulants may be useful
methylphenidate, 5 mg q am and q
noon, titrate
Respiratory
depression . . .
Opioid effects differ for patients treated
for extreme pain and at the end of life
pain is a potent stimulus to breathe
Depressed level of consciousness
precedes respiratory depression!!
. . . Respiratory
depression
Management
observe
Pain Assessment at
end of life
May be difficult in patient with dementia
or terminal delirium;
Vital signs not reliable indicator;
Moaning & groaning;
Objective signs:
Facial grimacing, frowning, furrowed brow
Increased agitation
Clenched jaw
Guarding
dying
patient
receiving
suboptimal
treatment
Death
death
Summary:
Equianalgesic Dosing
Quiz:
Thank You